Alterity Therapeutics (ATHE) Goodwill (2020)

Alterity Therapeutics (ATHE) recorded quarterly Goodwill of $119.1 million in Q4 2020, up 23.74% quarter-over-quarter from $96.3 million in Q2 2020.

Alterity Therapeutics (ATHE) Goodwill (2020) Analysis & Trends

Alterity Therapeutics' Goodwill history runs 1 years deep, the most recent figure standing at $119.1 million for Q4 2020.

In Q4 2020, Goodwill changed N/A year-over-year to $119.1 million; the TTM figure through Dec 2020 stood at $119.1 million (changed N/A YoY), while the FY2020 annual figure was $96.3 million, changed N/A from the prior year.
Goodwill was $119.1 million for Q4 2020 at Alterity Therapeutics, up from $96.3 million in the prior quarter.
In the past five years, Goodwill ranged from a high of $119.1 million in Q4 2020 to a low of $96.3 million in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn
9	Abivax	90.15 Bn	90.15 Bn	-
10	Regeneron Pharmaceuticals	63.59 Bn	54.83 Bn	3.31 Bn

Download Data

Date	Value
Dec 31, 2020	119.13 Mn
Jun 30, 2020	96.27 Mn